A biopharmaceutical company developing eyedrop treatment for Age Related Macular Degeneration wet AMD using VEGF alternative splicing.
Location: United Kingdom, England, Duxford
Total raised: $6.11M
Investors 7
| Date | Name | Website |
| - | o2h ventur... | o2hventure... |
| - | Angel CoFu... | acfinvesto... |
| - | BioCity | biocity.co... |
| - | Cambridge ... | cambridgea... |
| - | Parkwalk A... | parkwalkad... |
| - | Stoic VC | stoicvc.co... |
| - | Martlet | martletcap... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.02.2017 | - | $6.11M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 12.03.2024 | Exploristics and Exonate announce successful collaboration t... | Exploristics’ cloud-based simulation platform KerusCloud used to enhance study design for Exonate’s ... | cambridgen... |
| 29.11.2023 | Exonate diabetic macular oedema asset passes phase Ib/2a cha... | - | cambridgea... |
| 28.11.2023 | Exonate announces successful completion of Phase Ib/IIa tria... | Cambridgeshire and Nottingham, UK, 28 November 2023: Exonate Ltd., an mRNA therapy company focused o... | cambridgen... |
| 08.03.2019 | Top 21 #OnetoWatch recognition reflects the range of innovat... | Top 21 #OnetoWatch recognition reflects the range of innovation across the East of England 08-03-201... | cambridgen... |
| 06.02.2017 | Exonate Receives £4.9M Award by Wellcome Trust | Exonate, a Cambridge, UK-based early stage biotechnology company, received a £4.9m Seeding Drug Disc... | finsmes.co... |
| - | Exonate – University of Bristol Enterprise Fund II investmen... | We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk,... | parkwalkad... |
| - | Exonate – University of Bristol Enterprise Fund I investment... | We are delighted to announce that the University of Bristol Enterprise Fund I, managed by Parkwalk, ... | parkwalkad... |